In Pink Sheet, Katherine Wang Addresses Impact of China’s New Biosecurity Law

In The News
October 26, 2020

A Pink Sheet article reports that China has passed a sweeping new national Biosecurity Law, which will have a far-reaching impact on the life sciences industry in the country.

Life sciences regulatory & compliance partner Katherine Wang (Shanghai) explains that, under the new law, fines will increase significantly in cases where overseas organizations are alleged to have collected, preserved or exported Chinese human genetic resources. Katherine anticipates an increase in enforcement activity, and she encourages multinational life sciences companies to carefully review their ongoing research and commercial initiatives.